DionyMed Anticipates Appointment of Receiver and Resignation of Directors

TORONTO–(BUSINESS WIRE)–DionyMed Brands Inc. (“DionyMed” or the “Company“) (CSE: DYME; OTCQB: DYMEF), a multi-state cannabis brands, direct-to-consumer and distribution platform, previously announced that GLAS USA LLC (“GLAS USA”), as administrative agent, and GLAS America LLC (“GLAS America”), as collateral agent, under the Company’s credit agreement dated January 16, 2019 (as amended, supplemented or otherwise modified…

Tilray to Report Third Quarter 2019 Financial Results on November 12, 2019

NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, announced today it will report results for the third quarter ended September 30, 2019 on Tuesday, November 12, 2019 after market close. The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors…

Clear Cannabis, Inc. Opens Round of Private Funding with Boustead Securities, LLC.

DENVER–(BUSINESS WIRE)–Clear Cannabis, Inc. (CCI), leading cannabis distribution and infrastructure company in legal marijuana states, today announced it will be opening a crossover round of funding with Boustead Securities, LLC. The $10 million dollar raise is aimed to help CCI elevate brands and expand operations. “Our mission is supporting cannabis entrepreneurs in securing licenses, optimizing…

Shopify Announces Third-Quarter 2019 Financial Results

OTTAWA, Ontario–(BUSINESS WIRE)–Shopify Inc. (NYSE:SHOP)(TSX:SHOP), a leading global commerce company, today announced strong financial results for the quarter ended September 30, 2019. “More than a million merchants are now building their businesses on Shopify, as more entrepreneurs around the world reach for independence,” said Tobi Lütke, Shopify’s CEO. “These merchants chose Shopify because we’re making…

MedMen Announces Additional Amendments to Gotham Green Facility – Designated News Release

LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF) (“MedMen” or the “Company”) is pleased to announce certain amendments to its US$250,000,000 senior secured convertible credit facility (the “Facility”) arranged by Gotham Green Partners. As a result of the amendments to the Facility, the aggregate amount that remains available to be borrowed has not changed. However, in…

Eureka 93 Inc. Names Peter Ostapchuk as Chief Financial Officer

TORONTO–(BUSINESS WIRE)–Eureka 93 Inc. (CSE: ERKA, “Eureka93”) announced today that the Board of Directors has approved the appointment of Peter Ostapchuk as Chief Financial Officer, effective October 24, 2019. “With experience in financial reporting and related disclosures, restructuring and creating shareholder value, Mr. Ostapchuk has the breadth of knowledge to drive our renewed transformation” said…

MedMen Reports Fourth Quarter and Fiscal Year 2019 Financial Results – Designated News Release

LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) today released its consolidated financial results for fourth quarter and fiscal year ended June 29, 2019. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. Management Commentary “Fiscal 2019 was a transformative year for MedMen, with…

Transcat Strengthens Board of Directors with Appointment of Oksana S. Dominach

ROCHESTER, N.Y.–(BUSINESS WIRE)–Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has appointed Oksana S. “Sandy” Dominach as an independent director to its Board. Ms. Dominach brings more than…

Shareholder Alert: Robbins Arroyo LLP Announces Zynerba Pharmaceuticals, Inc. (ZYNE) Sued for Misleading Shareholders

SAN DIEGO & DEVON, Pa.–(BUSINESS WIRE)–Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between March 11, 2019 and September 17, 2019. Zynerba Pharmaceuticals operates as a clinical stage specialty pharmaceutical company.…